SPONSOR: Billington
Currently, a health care provider must not knowingly prescribe or administer cross-sex hormones or puberty blocking drugs for the purpose of a gender transition for any individual under 18 years of age.
This bill specifies that after March 1, 2026, prescriptions for cross-sex hormones or puberty-blocking drugs that were given to individuals under 18 years old for the purpose of assisting the individual with a gender transition prior to August 28, 2023, will no longer be considered valid.
The bill repeals the expiration clause for the related subsection.
This bill is the same as HB 1038 (2025).
Statutes affected: